Check out your Company Bowl for anonymous work chats.
Pam Cheng, our EVP, Global Operations, Global IT and Chief Sustainability Officer has been named by Fierce Pharma as one of its Fierce 50 Honorees of 2023. The Fierce 50 showcases companies and individuals driving advancements in medicine, fostering innovation and shaping the future of biopharma and healthcare. These individuals are recognized for pushing boundaries, defying limitations and igniting change in healthcare delivery, drug development, research and beyond. Learn more here: https://learn.az/6041uK8bD
Winning two 2023 Freezer Challenge Awards demonstrates our commitment to push the boundaries of science to deliver life-changing medicines in a way that is respectful of our planet. #WhatScienceCanDo
AstraZeneca's Young Health Programme supports the development of young leaders and youth-serving organisations to foster sustainable, collective leadership focused on improving youth health. Enkhuun Byambadorj's organisation, Breathe Mongolia equips young people with the tools to combat air pollution and advocate for sustainable policy change in their communities.
Our CEO Pascal Soriot and Dr. Victor Dzau, President of the National Academy of Medicine co-hosted a roundtable on decarbonizing healthcare in the U.S. and beyond. The focus was on how we can accelerate the delivery of net zero healthcare through advance policy changes. The climate crisis is a health crisis and we are putting it at the heart of everything we do. Spread the word to your networks.
Building a diverse talent pipeline at all levels of our organisation requires AstraZeneca to be a place where everybody, from all backgrounds, can feel a sense of belonging. By ensuring that AstraZeneca is the best that it can be, means our science will be as innovative as it can be and together, we harness our collective creativity and passions and do great things. Our agenda is flexible and our mission is strong: remove barriers and liberate minds. As a global organisation, we support a number of recognition events and days every year, such as International Women’s Day and Pride. These are culturally important to our team and we take the opportunity to celebrate and educate colleagues on a broad variety of topics that reflect the rich diversity of our workforce.
Mene Pangalos, Executive Vice President of BioPharmaceuticals Research and Development, has been awarded a knighthood by Her Majesty The Queen in the New Year 2020 Honours List in recognition of his services to UK science. Based in Cambridge, Mene has overall responsibility for AstraZeneca’s research and development (R&D) activities in BioPharmaceuticals. Since joining in 2010, he has pioneered programmes to promote novel Open Innovation partnerships with non-governmental and peer organisations, and more than 200 academic institutions to help drive the UK’s position as a world leader in life sciences R&D. Mene has also been the driving force behind an almost five-fold improvement in R&D productivity at AstraZeneca, measured by the number of pipeline molecules advancing from preclinical investigation to completion of Phase III clinical trials.
Huge congratulations to one of our apprentice Shaan Gill who has just received a ‘Highly Commended’ award from the Royal Society of Biology. This recognition is a direct result of her contribution to translational medicine during her time with us and her commitment to a voluntary secondment.
